Next Article in Journal
Cross-Cultural, Aboriginal Language, Discovery Education for Health Literacy and Informed Consent in a Remote Aboriginal Community in the Northern Territory, Australia
Next Article in Special Issue
Hemophagocytic Lymphohistiocytosis Associated with Scrub Typhus: Systematic Review and Comparison between Pediatric and Adult Cases
Previous Article in Journal
Global Burden and Challenges of Melioidosis
Previous Article in Special Issue
Rickettsial Infections and Q Fever Amongst Febrile Patients in Bhutan
Article Menu

Export Article

Open AccessArticle
Trop. Med. Infect. Dis. 2018, 3(1), 14; https://doi.org/10.3390/tropicalmed3010014

Development and Clinical Validation of a Multiplex Real-Time Quantitative PCR Assay for Human Infection by Anaplasma phagocytophilum and Ehrlichia chaffeensis

1
Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
2
Duke Hubert-Yeargan Center for Global Health, Durham, NC 27708, USA
3
Duke Global Health Institute, Durham, NC 27710, USA
4
Joint Departments of Pathology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Joint Pathology Center, Bethesda, MD 20814, USA
*
Author to whom correspondence should be addressed.
Received: 21 December 2017 / Revised: 19 January 2018 / Accepted: 21 January 2018 / Published: 29 January 2018
(This article belongs to the Special Issue The Past and Present Threat of Rickettsial Diseases)
Full-Text   |   PDF [481 KB, uploaded 29 January 2018]   |  

Abstract

Background: Human granulocytic anaplasmosis (HGA), caused by Anaplasma phagocytophilum, and human monocytic ehrlichiosis (HME), caused by Ehrlichia chaffeensis, often present as undifferentiated fever but are not treated by typical empiric regimens for acute febrile illness. Their role as agents of vector-borne febrile disease in tropical regions is more poorly studied than for other rickettsial infections. Limitations in diagnosis have impaired epidemiologic and clinical research and needless morbidity and mortality occur due to untreated illness. Methods: We designed and clinically validated a multiplex real-time quantitative PCR assay for Anaplasma phagocytophilum and Ehrlichia chaffeensis using samples confirmed by multiple gold-standard methods. Results: Clinical sensitivity and specificity for A. phagocytophilum were 100% (39/39) and 100% (143/143), respectively, and for E. chaffeensis 95% (20/21) and 99% (159/161), respectively. Conclusions: These assays could support early diagnosis and treatment as well as the high-throughput testing required for large epidemiologic studies. View Full-Text
Keywords: Ehrlichia chaffeensis; Anaplasma phagocytophilum; Rickettsiales; ticks; diagnostics; etiology of fever studies Ehrlichia chaffeensis; Anaplasma phagocytophilum; Rickettsiales; ticks; diagnostics; etiology of fever studies
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Reller, M.E.; Dumler, J.S. Development and Clinical Validation of a Multiplex Real-Time Quantitative PCR Assay for Human Infection by Anaplasma phagocytophilum and Ehrlichia chaffeensis. Trop. Med. Infect. Dis. 2018, 3, 14.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Trop. Med. Infect. Dis. EISSN 2414-6366 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top